Prestige Consumer Healthcare (PBH) Fails to deliver data

Key failure to deliver metrics for Prestige Consumer Healthcare:

• Last SEC data release: 2025-01-14
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$3.05 M
• Last year FTD volume: A$3.05 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Prestige Consumer Healthcare (PBH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Prestige Consumer Healthcare (PBH) - since 2013

Prestige Consumer Healthcare (PBH) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	A$95.08 M	A$0.14 B	🇬🇧 UK
Pfizer PFE	A$28.68 M	A$0.33 B	🇺🇸 USA
Rite Aid RAD	A$12.18 M	A$30.91 M	🇺🇸 USA
Johnson & Johnson JNJ	A$21.76 M	A$0.31 B	🇺🇸 USA
Taro Pharmaceutical TARO	N/A	A$0.78 M	🇮🇱 Israel
Novartis NVS	A$81.23 M	A$0.14 B	🇨🇭 Switzerland
Procter & Gamble PG	A$0.22 B	A$0.32 B	🇺🇸 USA
CVS Health CVS	A$64.16 M	A$0.21 B	🇺🇸 USA
Clorox CLX	A$84.9 M	A$0.10 B	🇺🇸 USA
Abbott Laboratories ABT	A$0.10 B	A$0.20 B	🇺🇸 USA